Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin
- PMID: 1794366
- DOI: 10.1007/BF02005451
Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin
Abstract
Development of resistance to nalidixic acid, norfloxacin and ciprofloxacin was observed in five patients with Campylobacter jejuni or Campylobacter coli infection. From all these patients nalidixic acid- and quinolone-susceptible strains were isolated initially, whereas after therapy with norfloxacin or ciprofloxacin strains resistant to these antibiotics were found. Campylobacter strains from the same patient always belonged to the same species and, with the exception of one case, showed identical rRNA gene restriction (rDNA) patterns. This indicates that double-infection with a susceptible and a resistant strain was not responsible for the phenomenon but rather that the infecting strain rapidly developed resistance following treatment.
Similar articles
-
Antimicrobial susceptibilities of Campylobacter jejuni and coli by using E-test in Taiwan.Scand J Infect Dis. 1998;30(1):39-42. doi: 10.1080/003655498750002286. Scand J Infect Dis. 1998. PMID: 9670357
-
Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients.J Antimicrob Chemother. 1997 Aug;40(2):257-61. doi: 10.1093/jac/40.2.257. J Antimicrob Chemother. 1997. PMID: 9301992
-
Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.Eur J Clin Microbiol Infect Dis. 1992 Dec;11(12):1163-6. doi: 10.1007/BF01961137. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1291314
-
The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.Appl Environ Microbiol. 2017 May 31;83(12):e00416-17. doi: 10.1128/AEM.00416-17. Print 2017 Jun 15. Appl Environ Microbiol. 2017. PMID: 28411226 Free PMC article. Review.
-
Two new fluoroquinolones: ciprofloxacin and norfloxacin.J Neurosci Nurs. 1988 Oct;20(5):327-28. doi: 10.1097/01376517-198810000-00011. J Neurosci Nurs. 1988. PMID: 2976793 Review. No abstract available.
Cited by
-
Antimicrobial resistance mechanisms among Campylobacter.Biomed Res Int. 2013;2013:340605. doi: 10.1155/2013/340605. Epub 2013 Jun 24. Biomed Res Int. 2013. PMID: 23865047 Free PMC article. Review.
-
Intracellular activity of azithromycin against bacterial enteric pathogens.Antimicrob Agents Chemother. 1994 Sep;38(9):1915-21. doi: 10.1128/AAC.38.9.1915. Antimicrob Agents Chemother. 1994. PMID: 7810998 Free PMC article.
-
Bacterial resistance to fluoroquinolones: lessons to be learned.Infection. 1994;22 Suppl 2:S140-7. doi: 10.1007/BF01793579. Infection. 1994. PMID: 7927833 Review.
-
Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.Antimicrob Agents Chemother. 1995 Sep;39(9):2019-22. doi: 10.1128/AAC.39.9.2019. Antimicrob Agents Chemother. 1995. PMID: 8540709 Free PMC article.
-
Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea.Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):612-5. doi: 10.1007/BF01971317. Eur J Clin Microbiol Infect Dis. 1994. PMID: 7805694
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical